These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 3146087

  • 1. [Intensive therapy of myasthenia gravis].
    Henze T.
    Psychiatr Neurol Med Psychol Beih; 1988; 40():74-8. PubMed ID: 3146087
    [No Abstract] [Full Text] [Related]

  • 2. [Electroacupuncture warming therapy combined with western medicine for treatment of myasthenia gravis and effect on IL-4 level in the patients].
    Wang SH, Cui X, Feng J.
    Zhongguo Zhen Jiu; 2007 Dec; 27(12):901-3. PubMed ID: 18271233
    [Abstract] [Full Text] [Related]

  • 3. [Usefulness of plasmapheresis before thymectomy in the management of myasthenia gravis].
    Iváñez V, Díez-Tejedor E, Lara M, Barreiro P.
    Neurologia; 1994 Dec; 9(7):277-81. PubMed ID: 7946422
    [Abstract] [Full Text] [Related]

  • 4. [Favorable results of plasmapheresis in severe myasthenia gravis].
    Blom RJ, Kuks JB, Westerterp-Maas A, Oosterhuis HJ.
    Ned Tijdschr Geneeskd; 1997 Feb 22; 141(8):381-4. PubMed ID: 9157298
    [Abstract] [Full Text] [Related]

  • 5. [Therapy of myasthenia (author's transl)].
    Birnberger KL, Struppler A.
    MMW Munch Med Wochenschr; 1976 Dec 17; 118(51):1653-6. PubMed ID: 187931
    [Abstract] [Full Text] [Related]

  • 6. [Plasmapheresis in the treatment of myasthenia gravis].
    Alvarez Sánchez B, Serrano Martín T, Merino de Cos P, Gutiérrez J, Pedauyle J, Verdú JJ, Fernández JA, Acedo A.
    Rev Clin Esp; 1976 Dec 17; 170(1-2):61-3. PubMed ID: 6635278
    [No Abstract] [Full Text] [Related]

  • 7. Long-term clinical outcome after extended thymectomy combined postoperative high-dose steroid therapy for juvenile myasthenia gravis.
    Kanzaki M, Obara T, Sasano S, Hikawa Y, Onuki T.
    Ann Thorac Cardiovasc Surg; 2008 Apr 17; 14(2):119-22. PubMed ID: 18414352
    [Abstract] [Full Text] [Related]

  • 8. Combined plasma exchange and immunosuppression in myasthenia gravis.
    Newsom-Davis J, Vincent A.
    Lancet; 1979 Sep 29; 2(8144):688. PubMed ID: 90770
    [No Abstract] [Full Text] [Related]

  • 9. [Letter: Therapy of myasthenia gravis pseudoparalytica].
    Hertel G, Ricker K.
    Dtsch Med Wochenschr; 1976 Feb 20; 101(8):301. PubMed ID: 1253742
    [No Abstract] [Full Text] [Related]

  • 10. Immunopharmacological treatment in myasthenia gravis.
    Nyberg-Hansen R, Gjerstad L.
    Transplant Proc; 1988 Jun 20; 20(3 Suppl 4):201-10. PubMed ID: 3289206
    [No Abstract] [Full Text] [Related]

  • 11. [Myasthenia gravis. A report on 3 cases].
    Ontiveros Lira D, Pérez Medina R, Trujillo Gómez JJ, Lugo Ibarra RJ.
    Ginecol Obstet Mex; 1988 Jan 20; 56():20-4. PubMed ID: 3154238
    [No Abstract] [Full Text] [Related]

  • 12. [Exchange plasmapheresis in the combined treatment of generalized myasthenia patients].
    Sazonov AM, Lipats AA, Kil'diushevskiĭ AV, Ol'shanskiĭ AIa, Guseva LL.
    Sov Med; 1984 Jan 20; (5):51-4. PubMed ID: 6087471
    [No Abstract] [Full Text] [Related]

  • 13. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J.
    Semin Neurol; 2003 Jun 20; 23(2):191-8. PubMed ID: 12894384
    [Abstract] [Full Text] [Related]

  • 14. [Respiratory insufficiency in myasthenia gravis].
    Kuks JB, Hylkema BS, Oosterhuis HJ.
    Ned Tijdschr Geneeskd; 1985 May 25; 129(21):996-1000. PubMed ID: 4010810
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of myasthenia gravis--pathophysiological evaluation of various forms of treatment and practical aspects of therapy (author's transl)].
    Ito N.
    No To Shinkei; 1980 Sep 25; 32(9):921-9. PubMed ID: 7437165
    [No Abstract] [Full Text] [Related]

  • 16. [Extracorporeal hemosorption in the intensive care of myasthenia].
    Lobzin VS, Obolenskiĭ SV, Rolle MN, Zhulev NM, Smirnov AN.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 Sep 25; 86(8):1153-5. PubMed ID: 3776389
    [Abstract] [Full Text] [Related]

  • 17. Differences may have contributed to differences noted in respiratory complications.
    Arsura EL.
    Crit Care Med; 2003 Jul 25; 31(7):2082-3. PubMed ID: 12847413
    [No Abstract] [Full Text] [Related]

  • 18. Topical therapy for oropharyngeal symptoms of myasthenia gravis.
    Dooley JM, Goulden KJ, Gatien JG, Gibson EJ, Brown BS.
    Ann Neurol; 1986 Feb 25; 19(2):192-4. PubMed ID: 3963762
    [Abstract] [Full Text] [Related]

  • 19. The role of plasma exchange in treatment of myasthenia gravis.
    Dau PC.
    Prog Clin Biol Res; 1982 Feb 25; 106():143-56. PubMed ID: 7178136
    [No Abstract] [Full Text] [Related]

  • 20. Plasma exchange therapy for severe penicillamine-induced myasthenia gravis.
    Lang AE, Humphrey JG, Gordn DA.
    J Rheumatol; 1981 Feb 25; 8(2):303-7. PubMed ID: 7230162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.